ArticleBiomedicines2026
Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells.
Abutaleb Asiri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.